Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.
D000284:Administration, Oral; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy*; D002699:Chlorambucil / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008207:Lymphatic Metastasis; D008408:Mastectomy; D008593:Menopause; D008727:Methotrexate / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local
D001500:BCG Vaccine; D002699:Chlorambucil; D005472:Fluorouracil; D008727:Methotrexate